Document Detail

Intravascular ultrasound and drug-eluting stents. Where are we now?
MedLine Citation:
PMID:  20145596     Owner:  NLM     Status:  MEDLINE    
Drug-eluting stents (DES) have revolutionized interventional cardiology. The profound ability of DES to suppress neointimal hyperplasia results in a reduced need for revascularization and improved clinical outcomes. DES, however, are not immune to in-stent restenosis. This problem particularly affects DES implanted for "off-label" indications and in challenging clinical and anatomic scenarios. In addition, as compared to bare-metal stents, DES do not reduce the incidence of stent thrombosis. Therefore, optimization of DES deployment is becoming increasingly important and, in this regard, intravascular ultrasound (IVUS) provides unique insights. IVUS assessment of neointimal growth has been of major value to understand the mechanisms of action of DES and also to compare different DES. Notably, IVUS enables optimization of DES implantation. DES underexpansion, edge-restenosis, residual dissections, plaque prolapse, stent fracture, incomplete stent apposition and DES-related aneurysms, are readily assessed by IVUS. The use of IVUS to study and manage DES failures (namely in-stent restenosis and DES thrombosis) is of major value. In conclusion, IVUS provides unique insights during DES implantation, allows DES optimization and should always be used during the management of DES failures: in-stent restenosis and DES thrombosis.
F Alfonso; J Dutary; V Rodriguez; B Zakhem
Related Documents :
20145596 - Intravascular ultrasound and drug-eluting stents. where are we now?
22565516 - Strength characteristics and marginal sealing ability of chlorhexidine-modified glass i...
3536946 - An editorial view on the reporting of results in heart valve bioprostheses.
10333026 - The influence of size mismatch on the hemodynamic performance of the pulmonary autograf...
15726846 - Early function of splinted implants in maxillas and posterior mandibles, using brånema...
23590786 - Reducing the risk of bone cement implantation syndrome during femoral arthroplasty.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Minerva cardioangiologica     Volume:  58     ISSN:  0026-4725     ISO Abbreviation:  Minerva Cardioangiol     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-10     Completed Date:  2010-09-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400725     Medline TA:  Minerva Cardioangiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  61-78     Citation Subset:  IM    
Cardiovascular Institute, Clinico San Carlos University Hospital, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coronary Aneurysm / therapy
Coronary Artery Disease / therapy,  ultrasonography
Drug-Eluting Stents* / adverse effects
Prosthesis Failure
Prosthesis Implantation / methods
Thrombosis / etiology
Ultrasonography, Interventional*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coronary chronic total occlusion.
Next Document:  Interventional treatment of congenital heart disease patients.